PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics, formerly known as PROCEPT THERAP, is based in San Jose, California.
| Revenue (Most Recent Fiscal Year) | $308.05M |
| Net Income (Most Recent Fiscal Year) | $-95.57M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.63 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.58 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -32.49% |
| Net Margin (Trailing 12 Months) | -32.53% |
| Return on Equity (Trailing 12 Months) | -30.62% |
| Return on Assets (Trailing 12 Months) | -22.10% |
| Current Ratio (Most Recent Fiscal Quarter) | 6.55 |
| Quick Ratio (Most Recent Fiscal Quarter) | 5.35 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.15 |
| Inventory Turnover (Trailing 12 Months) | 1.65 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.94 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.47 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.72 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.94 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 57.27M |
| Free Float | 54.98M |
| Market Capitalization | $1.22B |
| Average Volume (Last 20 Days) | 1.05M |
| Beta (Past 60 Months) | 0.91 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 89.46% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |